Enzyme’s Dual Role: Memory Guard and Inflammation Fighter
A team of scientists from Mass General Brigham, Harvard Stem Cell Institute and the Broad Institute has identified a brain‑protective enzyme that could slow or reverse cognitive decline associated with aging. Published this week in Nature Neuroscience, the study shows that a secreted phospholipase, sensitive to age‑related changes, can shield neurons and preserve memory function in animal models.
Wellness insights
Healing Journey: A Therapist Reflects on Processing Deep Childhood Trauma
Forest walks boost mood through sound and biodiversity awareness
What Counselling in Two Different Countries Taught Me: Hansel Wong on Connection, Curiosity, and Culture
Dr. LaNail Plummer Shares Insights on Starting TherapyThe research, led by Cinzia Vicidomini, PhD, and Amar Sahay, PhD, examined how the enzyme’s activity drops as mice age. They found that restoring its levels in older animals prevented the loss of synaptic connections and maintained performance in memory tests. The work suggests that the enzyme’s protective role is tied to its ability to remodel cell membranes and reduce harmful inflammation in the brain.
Vicidomini explained that the phospholipase acts like a maintenance crew for neurons. „It repairs membrane damage and dampens inflammatory signals that normally rise with age,” she said. The team used viral vectors to increase the enzyme’s expression in the hippocampus, the brain region critical for learning. Mice treated this way performed as well as young controls in maze navigation and object‑recognition tasks, while untreated older mice showed significant deficits.
Could a Single Protein Halt Dementia’s Progress?
The study also mapped the enzyme’s interaction with other aging markers. Researchers noted that its activity inversely correlated with levels of a protein known to accumulate in neurodegenerative diseases. This link points to a broader protective network that could be targeted for therapeutic development.
Sahay wondered whether boosting this enzyme could translate into human treatments. „We’re not there yet, but the data are compelling,” he said. The team plans to test the enzyme in larger animal models and explore small‑molecule activators that could cross the blood‑brain barrier. If successful, such drugs might complement existing approaches that focus on amyloid or tau proteins.
The research also raises questions about lifestyle factors that influence enzyme levels. Preliminary data suggest that exercise and certain diets may naturally enhance its activity, offering a non‑pharmacologic route to support brain health.
The discovery underscores the complexity of aging brains and the potential for precision interventions. While more work is needed before clinical trials, the findings open a promising avenue for preventing or slowing the cognitive decline that affects millions worldwide.
Frequently Asked Questions
What is the main finding of the study? The study shows that a specific phospholipase enzyme decreases with age but can be restored to protect neurons and maintain memory in older mice.
How might this research impact future treatments for dementia? If the enzyme’s protective effects can be replicated in humans, it could lead to new drugs that support brain resilience, potentially delaying or preventing dementia.
Are there any known lifestyle ways to boost this enzyme? Early data suggest that regular exercise and certain dietary patterns may increase the enzyme’s activity, but more research is needed to confirm these effects in humans.